Brain Scientific Inc
OTC:BRSF
Brain Scientific Inc
OTC:BRSF
Price:
0.0003
USD
Market Closed
Market Cap:
$372
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Brain Scientific Inc
OTC:BRSF
|
US |
|
Mav Beauty Brands Inc
TSX:MAV
|
CA |
|
C
|
Cantor Equity Partners VI Inc
NASDAQ:CEPS
|
US |
|
Katek Se
XETRA:KTEK
|
DE |
|
S
|
STMicroelectronics NV
XETRA:SGM
|
CH |
|
G
|
Good Shroom Co Inc
XTSX:MUSH
|
CA |
|
Agripower France SASU
PAR:ALAGP
|
FR |
|
Redco Properties Group Ltd
HKEX:1622
|
CN |
|
A
|
Aurora Solar Technologies Inc
F:A82
|
CA |
|
C
|
Clio Cosmetics Co Ltd
KOSDAQ:237880
|
KR |
|
Spectris PLC
LSE:SXS
|
UK |
|
L
|
L'Oreal SA
XETRA:LOR
|
FR |
|
Terns Pharmaceuticals Inc
NASDAQ:TERN
|
US |
|
Talon Metals Corp
TSX:TLO
|
VG |
|
E
|
eMudhra Ltd
NSE:EMUDHRA
|
IN |
|
Ene Technology Inc
TWSE:6243
|
TW |
|
Symphony International Holdings Ltd
LSE:SIHL
|
VG |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of BRSF.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BRSF
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
BRSF Competitors Multiples
Brain Scientific Inc Competitors
Brain Scientific Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Brain Scientific Inc
OTC:BRSF
|
372 USD | 0 | -0 | 0.1 | 0.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
176.8B USD | 4 | 27.1 | 15.5 | 21.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
160.8B USD | 16 | 56.3 | 42.6 | 52.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127B USD | 5.1 | 39.1 | 20 | 24.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.9B USD | 3.1 | 24 | 13.3 | 19.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
91.7B USD | 4.6 | 31.7 | 18.8 | 25.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.9B USD | 7.7 | 43.7 | 24 | 26.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40.5B EUR | 1.7 | 19.2 | 10.8 | 15.3 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.8B USD | 10.6 | 43.3 | 30.7 | 33.9 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.1B USD | 2 | 25.1 | 10 | 16.8 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32.9B USD | 6.1 | 22.2 | 15.6 | 17.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
